1) Present the current indications for Molecular Breast Imaging and Positron Emission Mammography. 2) Describe imaging protocols, radiation exposure and benefits for both techniques. 3) Outline the most common findings of benign and malignant breast lesion on MBI and PEM with correlation with other breast imaging studies. 4) Navigate through the different steps of PEM guided biopsy. 5)Describe alternative management and follow up with these techniques.
Integration of Nuclear Medicine in Breast Imaging
In the last decade the introduction of Nuclear medicine as Molecular imaging of the breast had a significant development in the diagnosis of breast abnormalities. Positron Emission Mammography (PEM) and Molecular Breast Imaging (MBI) have been successful in the detection of benign, atypical and malignant breast conditions.
PEM have been proven to represent a very helpful staging tool in patients with contraindications to breast MRI. MBI is a valuable technique for screening of high risk patients and as for problem solving for patients with inconclusive clinical or imaging findings.
This presentation will review the main indications of these Nuclear Medicine studies and will detail the findings and the correlation with conventional breast imaging. The breast imager will have a better understanding of the anatomic, functional and molecular breast imaging techniques.
Velasquez, M,
Mama: Integración de Medicina Nuclear en las Imágenes Diagnósticas de Mama/Breast: Nuclear Medicine Integration in Breast Imaging. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL.
http://archive.rsna.org/2014/14002960.html
